Registered entities
Cognition Therapeutics, Inc
Reg. No. 13-4365359United States
COGNITION THERAPEUTICS INC
Reg. No. 1455365United States
Innovation
21 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Construction; filing pace steady. Cited 3,983 times.
| Year | Filings |
|---|---|
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 5 |
Social engagement
Social engagement: 6.5K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
30 investors on record; lead investors include Golden Seeds.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 14 | 47% |
| Private equity | 2 | 7% |
| Angel & family office | 7 | 23% |
| Accelerator & incubator | 1 | 3% |
| Other / undisclosed | 6 | 20% |
Recent activity
12 Jun 2026
Event
Neuro Perspectives Expert Summit virtual fireside chat
4 Jun 2026
Event
2026 @Jefferies Global Healthcare Conference